Helena C. Bartels
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Helena C. Bartels has a total of 260 co-authors. Here are the top co-authors by number of shared publications:
- Donal J. Brennan
UCD Gynaecological Oncology Group, UCD School of Medicine, Mater Misericordiae University Hospital, Dublin, Ireland
12 shared publications Paul Downey
Department of Obstetrics and Gynecology, Department of Pathology, National Maternity Hospital, School of Medicine University College Dublin Dublin Ireland
11 shared publicationsDonal J. Brennan
University College Dublin Gynecological Oncology Group (UCD‐GOG), Mater Misericordiae University Hospital and St Vincent's University Hospital Dublin Ireland
8 shared publications- Fionnuala M. McAuliffe
UCD Perinatal Research Centre, School of Medicine, University College Dublin, National Maternity Hospital, Dublin, Ireland
7 shared publications - Eric Jauniaux
EGA Institute for Women's Health, Faculty of Population Health Sciences University College London (UCL) London UK
6 shared publications Constance Young
Department of Histopathology, National Maternity Hospital, Dublin, Ireland
5 shared publications
Latest Publications
- 16 July 2026
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 235 (5) , e126
Chronic histiocytic intervillositis and cell-free DNA fetal fraction (reply to letter to the editor)
- 16 July 2026
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 235 (5) , e126
Chronic histiocytic intervillositis and cell-free DNA fetal fraction (reply to letter to the editor)
- Open Access
- 16 July 2026
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 26 (1)
Towards precision medicine in placenta accreta spectrum: results from a survey-based evaluation of interactive academic international webinars
Placenta accreta spectrum (PAS) has emerged as a pressing global health concern as cesarean delivery rates continue to rise. Once regarded primarily as a placental disorder, PAS is now understood as an abnormal implantation process occurring within uterine scars. Although cesarean hysterectomy remains the predominant management strategy, growing evidence suggests that individualized, uterine-sparing approaches may reduce morbidity and better align with patient preferences. Traditional histopathologic classifications neither correlate with prenatal imaging findings nor reflect surgical complexity, thereby limiting their clinical utility. The PAS topographic classification, developed from intraoperative observations, offers a practical framework for surgical staging and guides patient-specific management strategies. Standardized prenatal ultrasound can anticipate surgical challenges and facilitate preoperative counseling. Despite this, few hospitals currently use this classification. This study qualitatively evaluated the impact of collaborative virtual educational activities designed to disseminate the concepts underlying the topographic classification on the surgical practice of PAS teams. Over a six-month period in 2024, interactive weekly webinars were conducted to discuss the evolving concepts in PAS that justify a shift toward precision medicine. Six months after the webinars concluded, a structured survey documented participants' perceptions of the impact of these sessions on the management of their PAS patients. A total of 112 invitations to participate in the survey were sent, and 91 responses were received (response rate: 81.2%). Among respondents, 97% (n = 88) reported that participation in the virtual academic discussions led to some change in their clinical practice. Thirty-four participants (37.4%) indicated that, following the webinars, they felt more confident proposing modifications to the management of patients at risk for PAS within their institutions. Participants reported that following the virtual academic discussions, they intended to use ultrasonographic evaluation to plan surgery (13 participants, 14.2%), implement individualized management based on topographic classification (18 participants, 19.8%), perform bladder dissection prior to fetal delivery in order to confirm placenta accreta spectrum (PAS) and assess its topography before selecting the appropriate treatment approach (8 participants, 8.8%). Virtual academic meetings designed to disseminate the PAS topographic classification fostered global collaboration, improved clinical practice, and enhanced mutual learning among PAS teams. Beyond technology, respectful, interactive discussions created a psychologically safe learning environment. Teleconferencing proved invaluable for education, research, and quality improvement, with continued support from professional societies essential for sustained progress.
- 16 July 2026
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 26 (1)
Open AccessTowards precision medicine in placenta accreta spectrum: results from a survey-based evaluation of interactive academic international webinars
Placenta accreta spectrum (PAS) has emerged as a pressing global health concern as cesarean delivery rates continue to rise. Once regarded primarily as a placental disorder, PAS is now understood as an abnormal implantation process occurring within uterine scars. Although cesarean hysterectomy remains the predominant management strategy, growing evidence suggests that individualized, uterine-sparing approaches may reduce morbidity and better align with patient preferences. Traditional histopathologic classifications neither correlate with prenatal imaging findings nor reflect surgical complexity, thereby limiting their clinical utility. The PAS topographic classification, developed from intraoperative observations, offers a practical framework for surgical staging and guides patient-specific management strategies. Standardized prenatal ultrasound can anticipate surgical challenges and facilitate preoperative counseling. Despite this, few hospitals currently use this classification. This study qualitatively evaluated the impact of collaborative virtual educational activities designed to disseminate the concepts underlying the topographic classification on the surgical practice of PAS teams. Over a six-month period in 2024, interactive weekly webinars were conducted to discuss the evolving concepts in PAS that justify a shift toward precision medicine. Six months after the webinars concluded, a structured survey documented participants' perceptions of the impact of these sessions on the management of their PAS patients. A total of 112 invitations to participate in the survey were sent, and 91 responses were received (response rate: 81.2%). Among respondents, 97% (n = 88) reported that participation in the virtual academic discussions led to some change in their clinical practice. Thirty-four participants (37.4%) indicated that, following the webinars, they felt more confident proposing modifications to the management of patients at risk for PAS within their institutions. Participants reported that following the virtual academic discussions, they intended to use ultrasonographic evaluation to plan surgery (13 participants, 14.2%), implement individualized management based on topographic classification (18 participants, 19.8%), perform bladder dissection prior to fetal delivery in order to confirm placenta accreta spectrum (PAS) and assess its topography before selecting the appropriate treatment approach (8 participants, 8.8%). Virtual academic meetings designed to disseminate the PAS topographic classification fostered global collaboration, improved clinical practice, and enhanced mutual learning among PAS teams. Beyond technology, respectful, interactive discussions created a psychologically safe learning environment. Teleconferencing proved invaluable for education, research, and quality improvement, with continued support from professional societies essential for sustained progress.
- 16 June 2026
- Published by Wolters Kluwer Health in Clinical Obstetrics and Gynecology
- Vol. 69 (4) , 478-482
Reconsidering the Role of Attempted Uterine Conservation by Intentional Placental Retention in Placenta Accreta Spectrum
Placenta accreta spectrum (PAS) is a rare complication associated with significant maternal morbidity and mortality. Historically, 2 surgical approaches emerged in the management of PAS, namely, hysterectomy or leaving the placenta in situ, hoping to avoid surgical morbidity and preserve future fertility. In this article, we argue that the risks of intentional placental retention for managing PAS outweigh the benefits, leaving patients unnecessarily exposed to the ongoing risk of hemorrhage and hysterectomy, with prolonged intensive follow-up required. Furthermore, histopathologic findings for these cases are inherently lacking, further limiting our ability to fully understand the underlying etiology of these cases.
- 16 June 2026
- Published by Wolters Kluwer Health in Clinical Obstetrics and Gynecology
- Vol. 69 (4) , 478-482
Reconsidering the Role of Attempted Uterine Conservation by Intentional Placental Retention in Placenta Accreta Spectrum
Placenta accreta spectrum (PAS) is a rare complication associated with significant maternal morbidity and mortality. Historically, 2 surgical approaches emerged in the management of PAS, namely, hysterectomy or leaving the placenta in situ, hoping to avoid surgical morbidity and preserve future fertility. In this article, we argue that the risks of intentional placental retention for managing PAS outweigh the benefits, leaving patients unnecessarily exposed to the ongoing risk of hemorrhage and hysterectomy, with prolonged intensive follow-up required. Furthermore, histopathologic findings for these cases are inherently lacking, further limiting our ability to fully understand the underlying etiology of these cases.
- Open Access
- 12 June 2026
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 23 (6) , e1005142
Placenta accreta spectrum in the 21st century: Challenging dogma and redefining disorder
Placenta accreta spectrum (PAS) is a serious pregnancy complication caused by abnormal placental attachment to the uterus. In this Perspective, Eric Jauniaux and colleagues discuss emerging evidence that challenges our long-held pathophysiological understanding of PAS, and argue that a critical reassessment of definition, diagnosis, and management is overdue.
- 12 June 2026
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 23 (6) , e1005142
Open AccessPlacenta accreta spectrum in the 21st century: Challenging dogma and redefining disorder
Placenta accreta spectrum (PAS) is a serious pregnancy complication caused by abnormal placental attachment to the uterus. In this Perspective, Eric Jauniaux and colleagues discuss emerging evidence that challenges our long-held pathophysiological understanding of PAS, and argue that a critical reassessment of definition, diagnosis, and management is overdue.
- Open Access
- 9 June 2026
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 105 (8) , 1435-1444
Placental basal plate with attached myofibers and adverse pregnancy outcomes: A systematic scoping review
Introduction: The finding of basal plate myometrial fibers (BPMF) delivered with the placenta has been associated with many different pregnancy and delivery complications. This study aims to evaluate the clinical utility of this histopathological finding in obstetrics. Material and Methods: We searched PubMed, Google Scholar, and Embase for studies published in English reporting an association between obstetric complications and placental BPMF, using combinations of relevant medical subject heading terms and keywords, published between March 1996 and December 2025. Study characteristics were evaluated by two independent reviewers using a predesigned protocol. The PRISMA Extension for Scoping Review (PRISMA‐ScR) was used to extract data and report the results. Results: Sixteen studies met our eligibility criteria for inclusion in this review. There were five cohorts and 11 studies, involving 5770 participants from four different countries. Nine studies reported on the association between BPMF on histopathologic examination in the setting of a delivered placenta and maternal or fetal pregnancy and delivery complications, and the remaining seven studies investigated the association between BPMF at birth in the index pregnancy and abnormal placental attachment at the next delivery. The most common prenatal and perinatal disorders were hypertensive disorders of pregnancy, placenta previa, preterm delivery, pre‐labor rupture of the membranes, suspicion of intrauterine infection, diabetes, stillbirth, and fetal growth restriction, and the most common intrapartum complications were placental abruption and placental retention. A higher incidence of abnormal placental attachment was reported in the subsequent pregnancy in cases where BPMF were found in the first pregnancy, but wide heterogeneity was observed across the included studies, particularly in the clinical criteria used to report placental attachment at delivery and interpretations of corresponding results. Conclusions: The clinical usefulness of reporting on BPMF in delivered placentas from pregnancies complicated by maternal or fetal disorders is currently difficult to evaluate due to variability in inclusion criteria, methodological protocols, and reported outcomes. The study of BPMF in delivered placentas may help fill evidence gaps in our knowledge of the pathophysiology of placental‐related pregnancy disorders involving the uteroplacental interface and the link between these disorders and long‐term maternal cardiovascular complications.
- 9 June 2026
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 105 (8) , 1435-1444
Open AccessPlacental basal plate with attached myofibers and adverse pregnancy outcomes: A systematic scoping review
Introduction: The finding of basal plate myometrial fibers (BPMF) delivered with the placenta has been associated with many different pregnancy and delivery complications. This study aims to evaluate the clinical utility of this histopathological finding in obstetrics. Material and Methods: We searched PubMed, Google Scholar, and Embase for studies published in English reporting an association between obstetric complications and placental BPMF, using combinations of relevant medical subject heading terms and keywords, published between March 1996 and December 2025. Study characteristics were evaluated by two independent reviewers using a predesigned protocol. The PRISMA Extension for Scoping Review (PRISMA‐ScR) was used to extract data and report the results. Results: Sixteen studies met our eligibility criteria for inclusion in this review. There were five cohorts and 11 studies, involving 5770 participants from four different countries. Nine studies reported on the association between BPMF on histopathologic examination in the setting of a delivered placenta and maternal or fetal pregnancy and delivery complications, and the remaining seven studies investigated the association between BPMF at birth in the index pregnancy and abnormal placental attachment at the next delivery. The most common prenatal and perinatal disorders were hypertensive disorders of pregnancy, placenta previa, preterm delivery, pre‐labor rupture of the membranes, suspicion of intrauterine infection, diabetes, stillbirth, and fetal growth restriction, and the most common intrapartum complications were placental abruption and placental retention. A higher incidence of abnormal placental attachment was reported in the subsequent pregnancy in cases where BPMF were found in the first pregnancy, but wide heterogeneity was observed across the included studies, particularly in the clinical criteria used to report placental attachment at delivery and interpretations of corresponding results. Conclusions: The clinical usefulness of reporting on BPMF in delivered placentas from pregnancies complicated by maternal or fetal disorders is currently difficult to evaluate due to variability in inclusion criteria, methodological protocols, and reported outcomes. The study of BPMF in delivered placentas may help fill evidence gaps in our knowledge of the pathophysiology of placental‐related pregnancy disorders involving the uteroplacental interface and the link between these disorders and long‐term maternal cardiovascular complications.
- Open Access
- 4 June 2026
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 235 (5) , 1152-1160
Outcome of cesarean scar ectopic pregnancy continued to viability: Data from the International Cesarean Scar Ectopic Pregnancy Registry
- 4 June 2026
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 235 (5) , 1152-1160
Open AccessOutcome of cesarean scar ectopic pregnancy continued to viability: Data from the International Cesarean Scar Ectopic Pregnancy Registry
- Open Access
- 20 March 2026
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 321, 115077
Use of magnetic resonance imaging as an adjunct to ultrasound for prenatal detection of placenta accreta spectrum
- 20 March 2026
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 321, 115077
Open AccessUse of magnetic resonance imaging as an adjunct to ultrasound for prenatal detection of placenta accreta spectrum